Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Mansur, Marcela B ^a   Hassan, Rocio ^a   Barbosa, Thayana C ^a   Splendore, Alessandra ^b   Jotta, Patricia Y ^c   Yunes, José A ^c   Wiemels, Joseph L ^d   Pombo de Oliveira, Maria S ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c CENTRO INFANTIL BOLDRINI   (Brazil)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; EVENT FREE SURVIVAL; FBXW7 GENE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUSION; GENE MUTATION; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NOTCH1 GENE; ONCOGENE K RAS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POINT MUTATION; PTEN GENE; SCHOOL CHILD; SIL TAL1 GENE; T CELL LEUKEMIA; TLX3 GENE; TUMOR GENE;

ADOLESCENT; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; F-BOX PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LEUKEMIA, T-CELL; MALE; MUTATION; ONCOGENE PROTEINS, FUSION; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, NOTCH1; UBIQUITIN-PROTEIN LIGASES;

EID: 84855418639     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-9     Document Type: Article

References (37)

1. Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008, 8(5):380-390. 10.1038/nri2304, 18421304.
2. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008, 371(9617):1030-1043. 10.1016/S0140-6736(08)60457-2, 18358930.
3. Breit S, Stanulla M, Flohr T, Schrappe M, Ludwig WD, Tolle G, Happich M, Muckenthaler MU, Kulozik AE. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 2006, 108(4):1151-1157. 10.1182/blood-2005-12-4956, 16614245.
4. Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH, Rowe JM, Caligiuri MA, Bloomfield CD, Look AT. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet 2004, 363(9408):535-536. 10.1016/S0140-6736(04)15542-6, 14975618.
5. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1(1):75-87. 10.1016/S1535-6108(02)00018-1, 12086890.
6. Mansur MB, Emerenciano M, Brewer L, Sant'Ana M, Mendonca N, Thuler LC, Koifman S, Pombo-de-Oliveira MS. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome. Leuk Lymphoma 2009, 50(8):1318-1325. 10.1080/10428190903040014, 19562638.
7. Aster JC, Blacklow SC, Pear WS. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J Pathol 2011, 223(2):262-273. 2996483, 20967796.
8. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991, 66(4):649-661. 10.1016/0092-8674(91)90111-B, 1831692.
9. Weng AP, Ferrando AA, Lee W, Morris J, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004, 306(5694):269-271. 10.1126/science.1102160, 15472075.
10. Grabher C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006, 6(5):347-359. 10.1038/nrc1880, 16612405.
11. Mullighan CG. Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia. Haematologica 2009, 94(10):1338-1340. 10.3324/haematol.2009.012047, 2754947, 19794079.
12. Pombo de Oliveira MS, Koifman S, Vasconcelos GM, Emerenciano M, de Oliveira Novaes C. Development and perspective of current Brazilian studies on the epidemiology of childhood leukemia. Blood Cells Mol Dis 2009, 42(2):121-125. 10.1016/j.bcmd.2008.10.012, 19064327.
13. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer -IARC, 2001 2001, Lyon: IARC Press, Jaffe ES, Harris NL, Stein H, Vardiman JW.
14. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2008, Lyon: IARC, Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW.
15. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003, 100(1):177-182. 10.1073/pnas.0126614100, 140919, 12509516.
16. Brandalise SR, Pinheiro VR, Aguiar SS, Matsuda EI, Otubo R, Yunes JA, Pereira WV, Carvalho EG, Cristofani LM, Souza MS, et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian childhood cooperative group--protocol ALL-99. J Clin Oncol 2010, 28(11):1911-1918. 10.1200/JCO.2009.25.6115, 20212252.
17. Moricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, Ludwig WD, Ritter J, Harbott J, Mann G, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010, 24(2):265-284. 10.1038/leu.2009.257, 20010625.
18. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995, 9(10):1783-1786.
19. Clappier E, Collette S, Grardel N, Girard S, Suarez L, Brunie G, Kaltenbach S, Yakouben K, Mazingue F, Robert A, et al. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia 2010, 24(12):2023-2031. 10.1038/leu.2010.205, 20861920.
20. Kox C, Zimmermann M, Stanulla M, Leible S, Schrappe M, Ludwig WD, Koehler R, Tolle G, Bandapalli OR, Breit S, et al. The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia 2010, 24(12):2005-2013. 10.1038/leu.2010.203, 3035973, 20944675.
21. Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffe M, Della Valle V, Monni R, Nguyen Khac F, Mercher T, Penard-Lacronique V, Pasturaud P, et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001, 15(10):1495-1504. 10.1038/sj.leu.2402249, 11587205.
22. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia 1999, 13(12):1901-1928. 10.1038/sj.leu.2401592, 10602411.
23. Bornholdt J, Hansen J, Steiniche T, Dictor M, Antonsen A, Wolff H, Schlunssen V, Holmila R, Luce D, Vogel U, et al. K-ras mutations in sinonasal cancers in relation to wood dust exposure. BMC Cancer 2008, 8:53. 10.1186/1471-2407-8-53, 2278146, 18289366.
24. Jotta PY, Ganazza MA, Silva A, Viana MB, da Silva MJ, Zambaldi LJ, Barata JT, Brandalise SR, Yunes JA. Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia. Leukemia 2010, 24(1):239-242. 10.1038/leu.2009.209, 19829307.
25. van Grotel M, Meijerink JP, van Wering ER, Langerak AW, Beverloo HB, Buijs-Gladdines JG, Burger NB, Passier M, van Lieshout EM, Kamps WA, et al. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia 2008, 22(1):124-131. 10.1038/sj.leu.2404957, 17928886.
26. Meijerink JP. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2010, 23(3):307-318. 10.1016/j.beha.2010.08.002, 21112032.
27. Paganin M, Ferrando A. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. Blood Rev 2011, 25(2):83-90. 10.1016/j.blre.2010.09.004, 20965628.
28. Larson Gedman A, Chen Q, Kugel Desmoulin S, Ge Y, LaFiura K, Haska CL, Cherian C, Devidas M, Linda SB, Taub JW, et al. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia 2009, 23(8):1417-1425. 10.1038/leu.2009.64, 2726275, 19340001.
29. Park MJ, Taki T, Oda M, Watanabe T, Yumura-Yagi K, Kobayashi R, Suzuki N, Hara J, Horibe K, Hayashi Y. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. Br J Haematol 2009, 145(2):198-206. 10.1111/j.1365-2141.2009.07607.x, 19245433.
30. Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu J, Gao XD, Chen B, Li JM, Xiong SM, et al. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res 2006, 12(10):3043-3049. 10.1158/1078-0432.CCR-05-2832, 16707600.
31. Dail M, Li Q, McDaniel A, Wong J, Akagi K, Huang B, Kang HC, Kogan SC, Shokat K, Wolff L, et al. Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents. Proc Natl Acad Sci USA 2010, 107(11):5106-5111. 10.1073/pnas.1001064107, 2841878, 20194733.
32. Kindler T, Cornejo MG, Scholl C, Liu J, Leeman DS, Haydu JE, Frohling S, Lee BH, Gilliland DG. K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors. Blood 2008, 112(8):3373-3382. 10.1182/blood-2008-03-147587, 2569181, 18663146.
33. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007, 13(10):1203-1210. 10.1038/nm1636, 2600418, 17873882.
34. Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y, Dahlberg S, Neuberg D, Moreau LA, Winter SS, et al. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 2009, 114(3):647-650. 10.1182/blood-2009-02-206722, 2713461, 19458356.
35. O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C, Hardwick J, Welcker M, Meijerink JP, Pieters R, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007, 204(8):1813-1824. 10.1084/jem.20070876, 2118656, 17646409.
36. Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G, Ferrando A, Aifantis I. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 2007, 204(8):1825-1835. 10.1084/jem.20070872, 2118676, 17646408.
37. Zuurbier L, Homminga I, Calvert V, te Winkel ML, Buijs-Gladdines JG, Kooi C, Smits WK, Sonneveld E, Veerman AJ, Kamps WA, et al. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia 2010, 24(12):2014-2022. 10.1038/leu.2010.204, 20861909.